Flucelvax 2025-2026 vaccine 0.5 ML Prefilled Syringe

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125408	Flucelvax, Flucelvax Quadrivalent	Influenza Vaccine	351(a)	Disc	2026-08-01

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Adverse event summaries are temporarily unavailable. Other product information remains available.

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
3513dfb0-4d62-4ad1-bb15-75c7555896ff	FLUCELVAX 2025-2026 vaccine 0.5 ML Prefilled Syringe [PSN] · 0.5 ML influenza A virus A/Georgia/12/2022 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Victoria/800/2024 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax 2025-2026] [SBD] · Flucelvax 2025-2026 vaccine 0.5 ML Prefilled Syringe [SY]	3	12	These highlights do not include all the information needed to use FLUCELVAX ® safely and effectively. See full prescribing information for FLUCELVAX. FLUCELVAX (Influenza Vaccine) Injectable Suspension, for Intramuscular Use 2025-2026 Formula Initial U.S. Approval: 2012	20260305
49ddaee7-fd56-ecb9-e063-6294a90a6ed6	FLUCELVAX 2025-2026 vaccine 0.5 ML Prefilled Syringe [PSN] · 0.5 ML influenza A virus A/Georgia/12/2022 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Victoria/800/2024 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax 2025-2026] [SBD] · Flucelvax 2025-2026 vaccine 0.5 ML Prefilled Syringe [SY]	3	1	FLUCELVAX (Influenza Vaccine) Injectable Suspension, for Intramuscular Use 2025-2026 Formula Initial U.S. Approval: 2012	20260202